NO964089L - Farmasöytisk kombinasjonspreparat for hormonell prevensjon - Google Patents
Farmasöytisk kombinasjonspreparat for hormonell prevensjonInfo
- Publication number
- NO964089L NO964089L NO964089A NO964089A NO964089L NO 964089 L NO964089 L NO 964089L NO 964089 A NO964089 A NO 964089A NO 964089 A NO964089 A NO 964089A NO 964089 L NO964089 L NO 964089L
- Authority
- NO
- Norway
- Prior art keywords
- hormone
- preparation
- pct
- estrogen
- daily
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4411585A DE4411585A1 (de) | 1994-03-30 | 1994-03-30 | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
PCT/EP1995/001190 WO1995026730A1 (de) | 1994-03-30 | 1995-03-30 | Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964089D0 NO964089D0 (no) | 1996-09-27 |
NO964089L true NO964089L (no) | 1996-11-07 |
Family
ID=6514578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964089A NO964089L (no) | 1994-03-30 | 1996-09-27 | Farmasöytisk kombinasjonspreparat for hormonell prevensjon |
Country Status (25)
Country | Link |
---|---|
US (1) | US5756490A (xx) |
EP (1) | EP0750501B1 (xx) |
JP (1) | JPH09511243A (xx) |
KR (1) | KR100352571B1 (xx) |
CN (1) | CN1108800C (xx) |
AT (1) | ATE222494T1 (xx) |
AU (1) | AU2073595A (xx) |
BG (1) | BG63192B1 (xx) |
BR (1) | BR9507251A (xx) |
CA (1) | CA2186739A1 (xx) |
CZ (1) | CZ291698B6 (xx) |
DE (2) | DE4411585A1 (xx) |
DK (1) | DK0750501T3 (xx) |
ES (1) | ES2181770T3 (xx) |
FI (1) | FI963831A (xx) |
HU (1) | HUT75521A (xx) |
NO (1) | NO964089L (xx) |
NZ (1) | NZ282824A (xx) |
PL (1) | PL316569A1 (xx) |
PT (1) | PT750501E (xx) |
RO (1) | RO118375B1 (xx) |
RU (1) | RU2165258C2 (xx) |
SK (1) | SK124396A3 (xx) |
UA (1) | UA41401C2 (xx) |
WO (1) | WO1995026730A1 (xx) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
PT792152E (pt) * | 1994-11-22 | 2004-07-30 | Balance Pharmaceuticals Inc | Metodos de contracepcao |
DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
AU726283B2 (en) * | 1995-06-28 | 2000-11-02 | Schering Aktiengesellschaft | Pharmaceutical combined preparations, kit and method for hormonal contraception |
DE19525017A1 (de) | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
WO1997041868A1 (en) * | 1996-05-08 | 1997-11-13 | American Home Products Corporation | Oral contraceptive |
US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
EP0917466B1 (en) * | 1996-07-26 | 2004-10-06 | Wyeth | Oral contraceptive |
US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
WO1998004267A1 (en) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
ES2223081T3 (es) * | 1996-07-26 | 2005-02-16 | Wyeth | Metodo anticonceptivo oral monofasico y kit que comprende una combinacion de progestina y estrogeno. |
US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
US6787531B1 (en) | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
EP2305267A3 (en) | 1999-08-31 | 2011-08-17 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
EP1214076B1 (en) * | 1999-08-31 | 2003-11-19 | Schering Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
CA2382426C (en) * | 1999-08-31 | 2006-02-28 | Schering Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
WO2003049744A1 (en) * | 2001-12-05 | 2003-06-19 | Barr Laboratories, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
JP2007534622A (ja) * | 2003-07-16 | 2007-11-29 | デュラメド ファーマシューティカルズ インコーポレーティッド | 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法 |
EP1673094A1 (en) * | 2003-10-01 | 2006-06-28 | Janssen Pharmaceutica N.V. | Extended triphasic contraceptive regimens |
EP1535618A1 (en) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
US20050113350A1 (en) * | 2003-11-26 | 2005-05-26 | Bernd Duesterberg | Extended use combination comprising estrogens and progestins |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
US7704984B2 (en) * | 2005-04-22 | 2010-04-27 | Warner Chilcott Company, Llc | Extended estrogen dosing contraceptive regimen |
US8063030B2 (en) * | 2006-03-02 | 2011-11-22 | Warner Chilcott Company, Llc | Extended cycle multiphasic oral contraceptive method |
US11376263B2 (en) | 2020-10-08 | 2022-07-05 | Fortress Biotech, Inc. | Cyproterone acetate compositions and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6615481A (xx) * | 1966-11-02 | 1968-05-03 | ||
US3639600A (en) * | 1969-08-28 | 1972-02-01 | Upjohn Co | Process of establishing cyclicity in a human female |
US4921843A (en) * | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
IE71203B1 (en) * | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
DE4104385C1 (xx) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich |
-
1994
- 1994-03-30 DE DE4411585A patent/DE4411585A1/de not_active Withdrawn
-
1995
- 1995-03-30 KR KR1019960705421A patent/KR100352571B1/ko not_active IP Right Cessation
- 1995-03-30 NZ NZ282824A patent/NZ282824A/en unknown
- 1995-03-30 RO RO96-01897A patent/RO118375B1/ro unknown
- 1995-03-30 CA CA002186739A patent/CA2186739A1/en not_active Abandoned
- 1995-03-30 PT PT95913171T patent/PT750501E/pt unknown
- 1995-03-30 EP EP95913171A patent/EP0750501B1/de not_active Expired - Lifetime
- 1995-03-30 UA UA96104081A patent/UA41401C2/uk unknown
- 1995-03-30 PL PL95316569A patent/PL316569A1/xx unknown
- 1995-03-30 ES ES95913171T patent/ES2181770T3/es not_active Expired - Lifetime
- 1995-03-30 SK SK1243-96A patent/SK124396A3/sk unknown
- 1995-03-30 CZ CZ19962879A patent/CZ291698B6/cs not_active IP Right Cessation
- 1995-03-30 RU RU96119957/14A patent/RU2165258C2/ru not_active IP Right Cessation
- 1995-03-30 AU AU20735/95A patent/AU2073595A/en not_active Abandoned
- 1995-03-30 HU HU9602657A patent/HUT75521A/hu unknown
- 1995-03-30 DK DK95913171T patent/DK0750501T3/da active
- 1995-03-30 US US08/718,401 patent/US5756490A/en not_active Expired - Fee Related
- 1995-03-30 WO PCT/EP1995/001190 patent/WO1995026730A1/de active IP Right Grant
- 1995-03-30 JP JP7525409A patent/JPH09511243A/ja not_active Ceased
- 1995-03-30 DE DE59510333T patent/DE59510333D1/de not_active Expired - Fee Related
- 1995-03-30 BR BR9507251A patent/BR9507251A/pt not_active Application Discontinuation
- 1995-03-30 CN CN95193056A patent/CN1108800C/zh not_active Expired - Fee Related
- 1995-03-30 AT AT95913171T patent/ATE222494T1/de not_active IP Right Cessation
-
1996
- 1996-09-25 FI FI963831A patent/FI963831A/fi not_active Application Discontinuation
- 1996-09-27 NO NO964089A patent/NO964089L/no unknown
- 1996-10-28 BG BG100940A patent/BG63192B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
HU9602657D0 (en) | 1996-11-28 |
KR100352571B1 (ko) | 2003-01-06 |
BG100940A (en) | 1998-03-31 |
DE59510333D1 (de) | 2002-09-26 |
NZ282824A (en) | 1998-07-28 |
CN1159161A (zh) | 1997-09-10 |
EP0750501A1 (de) | 1997-01-02 |
AU2073595A (en) | 1995-10-23 |
CA2186739A1 (en) | 1995-10-12 |
CN1108800C (zh) | 2003-05-21 |
DK0750501T3 (da) | 2002-12-23 |
BR9507251A (pt) | 1997-09-02 |
EP0750501B1 (de) | 2002-08-21 |
RO118375B1 (ro) | 2003-05-30 |
ATE222494T1 (de) | 2002-09-15 |
HUT75521A (en) | 1997-05-28 |
RU2165258C2 (ru) | 2001-04-20 |
UA41401C2 (uk) | 2001-09-17 |
JPH09511243A (ja) | 1997-11-11 |
SK124396A3 (en) | 1997-05-07 |
FI963831A0 (fi) | 1996-09-25 |
CZ291698B6 (cs) | 2003-05-14 |
FI963831A (fi) | 1996-11-29 |
MX9604440A (es) | 1997-07-31 |
ES2181770T3 (es) | 2003-03-01 |
WO1995026730A1 (de) | 1995-10-12 |
BG63192B1 (bg) | 2001-06-29 |
NO964089D0 (no) | 1996-09-27 |
DE4411585A1 (de) | 1995-10-05 |
PT750501E (pt) | 2003-01-31 |
PL316569A1 (en) | 1997-01-20 |
CZ287996A3 (en) | 1997-02-12 |
US5756490A (en) | 1998-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964089L (no) | Farmasöytisk kombinasjonspreparat for hormonell prevensjon | |
PT835114E (pt) | Preparado de combinacao farmaceutico kit e metodo para contracepcao hormonal | |
ES2086644T5 (es) | Preparado anovulatorio para la contracepcion hormonal. | |
NO974630D0 (no) | Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon | |
Van Santen et al. | Interception II: postcoital low-dose estrogens and norgestrel combination in 633 women | |
MXPA01010976A (es) | Uso de antiprogestagenos en terapia combinada. |